Matrix metalloproteinases in cancer: Prognostic markers and therapeutic targets
Pia Vihinen(Turku University Hospital), Veli‐Matti Kähäri(University of Turku)
Cited by 637
Related Papers
European Dermatology Forum S1‐guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes
|Journal of the European Academy of Dermatology and Venereology|2017|261
Smad3 Mediates Transforming Growth Factor-β-induced Collagenase-3 (Matrix Metalloproteinase-13) Expression in Human Gingival Fibroblasts
|Journal of Biological Chemistry|2002|102
Complement Component C3 and Complement Factor B Promote Growth of Cutaneous Squamous Cell Carcinoma
|American Journal Of Pathology|2017|94
Serpin Peptidase Inhibitor Clade A Member 1 (SerpinA1) Is a Novel Biomarker for Progression of Cutaneous Squamous Cell Carcinoma
|American Journal Of Pathology|2011|90
Matrix Metalloproteinase-19 Expression in Dermal Wounds and by Fibroblasts in Culture
|Journal of Investigative Dermatology|2003|67